A study indicates that the majority of patients using immune checkpoint inhibitors experience side effects, and radiation oncologists say that requirements for prior authorization are impeding care.

by Kate Yandell

The CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.

by Kate Yandell

Cancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.

by Kate Yandell

People with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.

by Marci A. Landsmann and Kate Yandell

The executive editor of Cancer Today previews the new issue.

by Kevin McLaughlin

A study suggests that 3-D mammograms may reduce unnecessary biopsies, and the U.S. Food and Drug Administration issues warnings to breast implant companies.

by Kate Yandell

NCI director steps in as FDA commissioner, new guidelines on clinical trial eligibility, and health risks for childhood cancer survivors.

by Bradley Jones

FDA Commissioner Scott Gottlieb resigns, an analysis explores patient advocacy groups' financial ties, and Alex Trebek announces he has pancreatic cancer.

by Marci A. Landsmann

A blood test for tumor mutations shows promise as an option for lung cancer patients, and the U.S. Food and Drug Administration expresses concern about robotically-assisted cancer surgery.

by Kate Yandell

Trials indicate that a combination of a targeted therapy and immunotherapy can treat advanced kidney cancer, and a study identifies a genetic variant associated with smoking menthol cigarettes.

by Kate Yandell